Amgen olpasiran may fill critical treatment gap in lowering Lp(a): GlobalData
The latest data from the final analysis of the Phase II OCEAN(a)-DOSE study showed that olpasiran reduced Lp(a) levels in patients…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Olpasiran
Amgen announces positive phase-II data for investigational Olpasiran in adults with elevated…
The study showed significant and sustained reduction in lipoprotein(a) during treatment period